Combined Treatment of Type 2 Diabetes and Hypothyroidism: Impact of Oral Semaglutide and Levothyroxine on Cardiometabolic and Thyroid Parameters: A 6-Month Comparative Study
The concurrent administration of oral semaglutide and levothyroxine produces additive cardiometabolic advantages in individuals with T2DM and hypothyroidism. These findings suggest that combined treatment may optimize metabolic outcomes in this particularly high-risk population.
Authors
- CRISTIAN GUJA
- Dana-Mihaela Tilici
- Diana Loreta Păun
- Dana-Mihaela Tilici (ORCID: https://orcid.org/0009-0001-5655-2694)
- Mirona Costea
- Beatrice Mihaela Grecu
Institutions
- Carol Davila University of Medicine and Pharmacy (RO)
- Avila University (US)
- Clinical Emergency Hospital Bucharest (RO)
- Emergency University (US)
Publication Details
- Journal
- Epidemiologia
- Published
- 2026-03-04
- DOI
- https://doi.org/10.3390/epidemiologia7020041
- Primary Topic
- Thyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00